Due to the extirpation of their natural predators, feral horse populations have expanded across the United States, necessitating their management. Contraception of females (mares) with porcine zona pellucida (PZP) is a popular option; however, effects to physiology and behavior can be substantial. On Shackleford Banks, North Carolina, USA, treated mares have exhibited cycling during the non-breeding season and demonstrated decreased fidelity to the band stallion, but PZP's long-term effects on mare physiology and behavior remain largely unexplored. After the contraception program was suspended in this population, we examined how prior exposure to varying levels of PZP treatment impacted (1) foaling probability and foaling dates (a proxy for ovulatory cycling) from 2009 to 2014 and (2) mare fidelity to the band stallion and reproductive behavior during 2013 and 2015. Additionally, we evaluated the effects of time since the mares' last treatment on these factors. Mares receiving any level of prior PZP treatment were less likely to foal than were untreated mares. Among mares that received 1-3 PZP applications, foaling probability increased with time since last treatment before declining, at ~6 years post-treatment. Mares that received 4+ applications did not exhibit a significant increase in foaling probability with time since last treatment. Moreover, previously treated mares continued to conceive later than did untreated mares. Finally, mares previously receiving 4+ treatments changed groups more often than did untreated mares, though reproductive behavior did not differ with contraception history. Our results suggest that although PZP-induced subfertility and its associated behavioral effects can persist after the cessation of treatment, these effects can be ameliorated for some factors with less intense treatment. Careful consideration to the frequency of PZP treatment is important to maintaining more naturally functioning populations; the ability to manage populations adaptively may be compromised if females are kept subfertile for extended periods of time.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007543 | PMC |
http://dx.doi.org/10.1093/conphys/cox018 | DOI Listing |
Animals (Basel)
December 2024
Science and Conservation Center, 2100 South Shiloh Road, Billings, MT 59106, USA.
Wildlife managers and the public have expressed considerable interest in the use of contraception to help manage the populations of wild horses and burros ( and ). Field testing has shown that two preparations of the porcine zona pellucida (PZP) vaccine, a simple emulsion (ZonaStat-H) and PZP-22 (which supplements ZonaStat-H with a controlled-release component) effectively prevent pregnancy in individual mares and can substantially reduce population foaling rates. To determine whether some PZP preparations might have secondary effects that harm treated mares or their foals, we examined the effects of PZP-22 vaccinations and the follow-up boosters of either PZP-22 or ZonaStat-H on adult female body condition, foaling season, and foal mortality in two wild horse herds in the western USA, Cedar Mountains Herd Management Area, Utah (CM; 2008-2015), and Sand Wash Basin Herd Management Area, Colorado (SWB; 2008-2014).
View Article and Find Full Text PDFCirc Genom Precis Med
October 2024
Program in Medical and Population Genetics and Cardiovascular Disease Initiative (B.T., A.S., P.N., M.C.H.).
Background: Preeclampsia is a leading cause of maternal and perinatal morbidity and mortality. However, the current understanding of its underlying biological pathways remains limited.
Methods: In this study, we performed a cross-platform proteome- and transcriptome-wide genetic analysis aimed at evaluating the causal relevance of >2000 circulating proteins with preeclampsia, supported by data on the expression of over 15 000 genes across 36 tissues leveraging large-scale preeclampsia genetic association data from women of European ancestry.
PLoS One
June 2024
The First Affiliated Hospital/Clinical Medical School, Guangdong Pharmaceutical University, Guangzhou, China.
Glioblastoma, the most aggressive form of brain cancer, poses a significant global health challenge with a considerable mortality rate. With the predicted increase in glioblastoma incidence, there is an urgent need for more effective treatment strategies. In this study, we explore the potential of caerin 1.
View Article and Find Full Text PDFJ Transl Med
May 2024
Department of Oncology, Hangzhou Cancer Hospital, No.34 Yanguan Lane, Shangcheng District, Hangzhou, 310002, China.
AAPS PharmSciTech
May 2024
Translational Pharmaceutics Research Laboratory, Department of Pharmacy, Birla Institute of Technology and Science, Hyderabad, Pilani, India.
Pancreatic ductal adenocarcinoma (PDAC) is one of the highly fatal types of cancer with high mortality/incidence. Considering the crucial role of vascular endothelial growth factor (VEGF) in PDAC progression, its inhibition can be a viable strategy for the treatment. Pazopanib, a second-generation VEGF inhibitor, is approved for the treatment of various oncological conditions.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!